RS2388334 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (18)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Cerebellar grey matter morphology (MOSTest) | G | — | 4E-58 | PubMed |
| Leg fat percentage right (UKB data field 23111) | G | β: 0.013 | 1E-30 | PubMed |
| General cognitive ability | A | OR: 11.47 | 2E-30 | PubMed |
| Verbal-numerical reasoning | — | — | 1E-21 | PubMed |
| Arm fat percentage left (UKB data field 23123) | G | β: 0.014 | 1E-21 | PubMed |
| Trunk fat mass (UKB data field 23128) | G | β: 0.017 | 2E-20 | PubMed |
| Arm fat percentage right (UKB data field 23119) | G | β: 0.013 | 2E-19 | PubMed |
| Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)) | — | β: 0.027 | 1E-12 | PubMed |
| Autism and educational attainment (MTAG) | A | β: 0.065 | 3E-12 | PubMed |
| Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | — | — | 1E-11 | PubMed |
| Risk-taking tendency (4-domain principal component model) | A | β: 0.016 | 2E-10 | PubMed |
| Bipolar disorder or glomerular filtration rate estimated from cystatin (MTAG) | — | — | 3E-9 | PubMed |
| Bipolar disorder | A | OR: 0.94 | 4E-9 | PubMed |
| Bipolar disorder | G | OR: 1.07 | 4E-9 | PubMed |
| Gastroesophageal reflux disease or bipolar disorder (pleiotropy) | — | — | 2E-8 | PubMed |
| Cystatin C levels in bottom 99% of individuals by creatinine levels | — | β: 0.002 | 3E-8 | PubMed |
| School performance E-factor 1 (overall performance) | G | β: 0.041 | 4E-8 | PubMed |
| Bipolar I disorder | G | OR: 1.08 | 3E-7 | PubMed |